Earningsreport

Q2/2025 9/30/2024 EPS 15.050 ZacksConsensus 0.990 ActVsEst 14.060 - Beat

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors